BECTON DICKINSON & CO (BDX)
Data as of , from SEC Form 4 filings.
See up to 3 months of BDX. The 7-day demo opens the 1M and 3M ranges and puts BDX on your watchlist.
Start 7-day demoLatest BDX insider trades
Michael Feld - OfficerOpen-market sale$14K- Michael Feld - OfficerOpen-market sale
About BECTON DICKINSON & CO (BDX)
BECTON DICKINSON & CO is an SEC registrant, filing under CIK 0000010795, classified as surgical and medical instruments and apparatus. We track it alongside the rest of the Health Care sector.
BDX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 5 | 6,906 | $1.27M |
| Grant or award | 2 | 283 | |
| Option exercise | 2 | 86,556 | |
BDX insider transactions (Form 4)
4996 Form 4 filings on record, the earliest from Nov 5, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jeffrey William Henderson - Director | Grant or award | Common Stock | 1,098 footnote F1 | $0.00 | - | |
| ||||||
| R. Andrew Eckert - Director | Grant or award | Common Stock | 1,098 footnote F1 | $0.00 | - | |
| ||||||
| Carrie L. Byington - Director | Grant or award | Common Stock | 1,098 footnote F1 | $0.00 | - | |
| ||||||
 Gregory Hayes - Director | Grant or award | Common Stock | 1,098 footnote F1 | $0.00 | - | |
| ||||||
| William M. Brown - Director | Grant or award | Common Stock | 1,098 footnote F1 | $0.00 | - | |
| ||||||
| Robert Luther Huffines - Director | Grant or award | Common Stock | 1,098 footnote F1 | $0.00 | - | |
| ||||||
| Christopher Ian Montague Jones - Director | Grant or award | Common Stock | 1,098 footnote F1 | $0.00 | - | |
| ||||||
 Timothy M. Ring - Director | Grant or award | Common Stock | 1,098 footnote F1 | $0.00 | - | |
| ||||||
 Bertram L. Scott - Director | Grant or award | Common Stock | 1,098 footnote F1 | $0.00 | - | |
| ||||||
| Joanne Waldstreicher - Director | Grant or award | Common Stock | 1,098 footnote F1 | $0.00 | - | |
| ||||||
| Jacqueline Wright - Director | Grant or award | Common Stock | 1,098 footnote F1 | $0.00 | - | |
| ||||||
| Michael Feld - Officer | Open-market sale | Common Stock | 75 | $202.73 | $15K | |
| Pamela L. Spikner - Officer | Tax withholding / forfeiture | Common Stock | 84 footnote F1 | $0.00 | - | |
| ||||||
 Michael David Garrison - Officer | Option exercise | Common Stock | 3,054 | $167.91 | $513K | |
| Michael David Garrison - Officer | Derivative | Common Stock | 2,454 | $209.00 | $513K | |
| Michael David Garrison - Officer | Open-market sale | Common Stock | 600 | $209.00 | $125K | |
| Michael David Garrison - Officer | Open-market sale | Common Stock | 1,010 | $206.54 | $209K | |
| Michael David Garrison - Officer | Option exercise | Stock Appreciation Rights | 3,054 | $0.00 | - | |
| Michael Feld - Officer | Open-market sale | Common Stock | 75 | $193.36 | $15K | |
| Jacqueline Wright - Director | Grant or award | Common Stock | 180 footnote F1 | $0.00 | - | |
| ||||||
| Robert Luther Huffines - Director | Grant or award | Common Stock | 180 footnote F1 | $0.00 | - | |
| ||||||
| Pavan Kumar Mocherla - Officer | Grant or award | Common Stock | 2,208 footnote F1 | $0.00 | - | |
| Pavan Kumar Mocherla - Officer | Grant or award | Common Stock | 708 footnote F2 | $0.00 | - | |
| ||||||
 David Shan - Officer | Grant or award | Common Stock | 3,504 footnote F1 | $0.00 | - | |
| David Shan - Officer | Grant or award | Common Stock | 1,025 footnote F2 | $0.00 | - | |
| David Shan - Officer | Tax withholding / forfeiture | Common Stock | 134 footnote F3 | $0.00 | - | |
| ||||||
 Shana Carol Neal - Officer | Grant or award | Common Stock | 6,727 footnote F1 | $0.00 | - | |
| Shana Carol Neal - Officer | Grant or award | Common Stock | 3,525 footnote F2 | $0.00 | - | |
| Shana Carol Neal - Officer | Tax withholding / forfeiture | Common Stock | 2,454 footnote F3 | $0.00 | - | |
| ||||||
| Roland Goette - Officer | Grant or award | Common Stock | 1,906 footnote F1 | $0.00 | - | |
| Roland Goette - Officer | Grant or award | Common Stock | 1,237 footnote F2 | $0.00 | - | |
| Roland Goette - Officer | Tax withholding / forfeiture | Common Stock | 138 footnote F3 | $0.00 | - | |
| ||||||
| Michael David Garrison - Officer | Grant or award | Common Stock | 7,568 footnote F1 | $0.00 | - | |
| Michael David Garrison - Officer | Grant or award | Common Stock | 3,048 footnote F2 | $0.00 | - | |
| Michael David Garrison - Officer | Tax withholding / forfeiture | Common Stock | 1,769 footnote F3 | $0.00 | - | |
| ||||||
| Michael Feld - Officer | Grant or award | Common Stock | 8,829 footnote F1 | $0.00 | - | |
| Michael Feld - Officer | Tax withholding / forfeiture | Common Stock | 419 footnote F2 | $0.00 | - | |
| ||||||
 Christopher Delorefice - Officer | Grant or award | Common Stock | 6,006 footnote F1 | $0.00 | - | |
| Christopher Delorefice - Officer | Tax withholding / forfeiture | Common Stock | 4,245 footnote F2 | $0.00 | - | |
| ||||||
 Richard Byrd - Officer | Grant or award | Common Stock | 6,447 footnote F1 | $0.00 | - | |
| Richard Byrd - Officer | Grant or award | Common Stock | 2,385 footnote F2 | $0.00 | - | |
| Richard Byrd - Officer | Tax withholding / forfeiture | Common Stock | 1,719 footnote F3 | $0.00 | - | |
| ||||||
| Bilal Muhsin - Officer | Grant or award | Common Stock | 9,530 footnote F1 | $0.00 | - | |
| ||||||
| Thomas E. Polen Jr. - Officer | Grant or award | Common Stock | 22,521 footnote F1 | $0.00 | - | |
| Thomas E. Polen Jr. - Officer | Tax withholding / forfeiture | Common Stock | 17,421 footnote F2 | $0.00 | - | |
| Thomas E. Polen Jr. - Officer | Grant or award | Stock Appreciation Rights | 165,581 | $0.00 | - | |
| ||||||
| Pamela L. Spikner - Officer | Grant or award | Common Stock | 1,234 footnote F1 | $0.00 | - | |
| ||||||
| Bertram L. Scott - Director | Open-market sale | Common Stock | 217 | $176.58 | $38K | |
| Carrie L. Byington - Director | Grant or award | Rights to Common Stock Under BD Deferred Compensation Plan | 34 | $178.71 | $6K | |
Item 2.02, 9.01
Item 5.02, 7.01, 9.01
Item 7.01
Item 1.01, 2.03, 9.01
Recent BDX Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| MICHAEL FELD | Officer | 76 | $14K | View on EDGAR | |
| MICHAEL FELD | Officer | 165 |
Stock trades in BDX disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
 Thomas H. Kean, Jr.Republican, NJ-07 | Sale |
BDX insider trading FAQ
What is the latest insider trade for BDX?
BECTON DICKINSON & CO (BDX) had 9 insider filings in the last 90 days, with the most recent on 2026-09-30. The full record for BDX runs to 96 Form 4 filings, the earliest from 2024-11-05. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying BDX stock?
No insider purchases of BDX were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling BDX stock?
5 insider sales of BDX were filed in the last 90 days, totaling $1.27M.
Where can I see BDX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects BDX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Michael Feld view on EDGAR
- - Vitor Roque view on EDGAR
- - Michael Feld view on EDGAR
- - Michael Feld view on EDGAR
- - Thomas E. Polen Jr. view on EDGAR
- - Roland Goette view on EDGAR
- - Robert Luther Huffines view on EDGAR
- - Carrie L. Byington view on EDGAR
- - Michael Feld view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where BDX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow BDX with a 7-day demo
- BDX on your watchlist
- Every BDX Form 4 filing on record
- Up to 3 months of BDX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
